Invitae 

€0.000000
0
+€0.00+0% 00:00 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

其他人也在關注

此清單是根據在 Stock Events 上追蹤 IV8.MU 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. It serves patients, healthcare providers, biopharma companies, and other partners. It has a collaboration with Pacific Biosciences of California, Inc. to develop a production-scale high-throughput HiFi sequencing platform. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Show more...
執行長
Dr. Sean Emerson George Ph.D.
員工
2600
國家
美國
ISIN
US46185L1035

上市

0 Comments

分享你的想法

FAQ

Invitae 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Invitae 的股票以代號 IV8.MU 進行交易。
Invitae 有多少名員工?
截至 July 08, 2026,公司共有 2,600 名員工。
Invitae 位於哪個產業?
Invitae從事於Health & Wellness產業。
Invitae 何時完成拆股?
Invitae 最近沒有進行任何拆股。
Invitae 的總部在哪裡?
Invitae 的總部位於 美國 的 San Francisco。